Hareesha Babu MD,DM,FASN,FRCP(Glasg), FRCP Edin

@arvindcanchi @sundar_s1955 @BMTheEquityDesk

Newly released 🔥🔥 Updated NICE Guidelines: Initial Pharmacologic Management of Type 2 Diabetes: 🔵 Chronic kidney disease: 🔵 eGFR >30: Metformin MR + SGLT-2 inhibitor; if metformin not tolerated → SGLT-2 inhibitor alone. 🔵 eGFR 20–30: Dapagliflozin or empagliflozin + DPP-4 inhibitor. 🔵 eGFR <20: Consider DPP-4 inhibitor; if unsuitable → consider pioglitazone or insulin. #Cardiology #MedTwitter #CardioTwitter #HeartHealth #Healthcare @mvaduganathan @hvanspall @ShelleyZieroth @DrMarthaGulati @goKDIGO @ASNKidney @biljana_parapid @Hragy nice.org.uk/guidance/ng28/…

2025 EULAR guidelines for LN -Biopsy is key for dx -Early combo ttx -T2T proteinuria -Aggressive management of severe disease #RWCS2026 @RheumNow

Gout m/g in CKD

🫘Nephrology Syndromes Source Harrison

🫘💯Easy guide to AKI From @Neph_SIM

👍New Lupus Nephritis guidelines #ACR2024 🤘Major change-Triple therapy for induction ✅

Ventilator induced Acute Kidney Injury

Benefits of Dapagliflozin

@arvindcanchi @sundar_s1955 @BMTheEquityDesk

Kidney transplant recipients receiving GLP-1 RA had a 49% lower incidence of death-censored graft loss and 31% lower mortality than those not receiving GLP-1 RA 🤯 Proud to be a co-author on this real-world retrospective cohort study of 18,106 kidney transplant recipients with diabetes published today in Lancet Diabetes and Endocrinology🙂 Article: sciencedirect.com/science/articl… Accompanying commentary: thelancet.com/journals/landi…

Type of probe #ultrasound #sonologist

🦠Hepatitis B serology By @PathwayMedical

Role of Magnesium in ESRD